Clorox (CLX) Research & Development (2009 - 2026)

Clorox's Research & Development history runs 18 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• On a quarterly basis, Research & Development changed 0.0% year-over-year to $27.0 million in Q1 2026; TTM through Mar 2026 was $116.0 million, a 4.92% decrease from a year earlier, with the FY2025 full-year figure at $121.0 million, down 3.97% from the prior year.
• Research & Development declined to $27.0 million in Q1 2026 per CLX's latest filing, from $29.0 million in the prior quarter.
• Across five years, Research & Development topped out at $38.0 million in Q2 2023 and bottomed at $27.0 million in Q1 2025.
• The 5-year median for Research & Development is $32.0 million (2022), against an average of $31.4 million.
• Across the five-year window, Research & Development dropped 24.44% in 2022 and advanced 12.9% in 2023, its largest moves.
• Year by year, Research & Development stood at $33.0 million in 2022, then retreated by 3.03% to $32.0 million in 2023, then dropped by 3.12% to $31.0 million in 2024, then declined by 6.45% to $29.0 million in 2025, then fell by 6.9% to $27.0 million in 2026.
• Per Business Quant, the three latest CLX Research & Development figures stand at $27.0 million (Q1 2026), $29.0 million (Q4 2025), and $28.0 million (Q3 2025).